A Study of ALTA3263 in People With Solid Tumor Cancer

Full Title

3263-001: A Phase 1/1b Multiple Cohort Trial of ALTA3263 in Patients With Advanced Solid Tumors With KRAS Mutations

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Rona Yaeger’s office at 646-888-4226.

Protocol
26-397
Phase
Phase I (phase 1)
Investigator
Rona Yaeger
Co-Investigators
Kathryn C. Arbour
Diseases
Colorectal Cancer
Lung Cancer › Lung Cancer, Non-Small Cell
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06835569
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description